News & Updates

Show Multimedia Only

Spirulina dietary supplement beneficial for COVID-19?

26 Aug 2024 by

Supplementing standard COVID-19 treatment with Spirulina – a nutrient-rich superfood – may improve recovery and reduce mortality in hospitalized COVID-19 patients, a study from Iran suggests.

Spirulina dietary supplement beneficial for COVID-19?

26 Aug 2024

CPAP treatment may reduce pregnancy complications in expectant mums with sleep apnoea

23 Aug 2024

In pregnant women with obstructive sleep apnoea (OSA), continuous positive airway pressure (CPAP) treatment helps lower the risk of gestational hypertension and pre-eclampsia, according to the results of a meta-analysis.

CPAP treatment may reduce pregnancy complications in expectant mums with sleep apnoea

23 Aug 2024

Rheumatoid arthritis carries increased lung cancer risk

22 Aug 2024

Rheumatoid arthritis (RA) appears to convey a 50-percent increase in the risk of lung cancer, with the risk increase even more pronounced for individuals with RA-interstitial lung disease (ILD), according to a study

Rheumatoid arthritis carries increased lung cancer risk

22 Aug 2024

OCS use improves short-term outcomes in acute preschool wheeze

19 Aug 2024 by

In a systematic review and individual participant data (IPD) meta-analysis, the use of oral corticosteroids (OCS) improves short-term outcomes in children aged 12–71 months with acute preschool wheeze, more so among children with previous wheeze or asthma and those with moderate-to-severe acute wheeze.

OCS use improves short-term outcomes in acute preschool wheeze

19 Aug 2024

Filgrastim tied to higher ACR burden in lung transplant recipients

15 Aug 2024

Use of filgrastim among lung transplant recipients (LTRs) for the treatment of neutropenia contributes to an increased burden of acute cellular rejection (ACR) and a reduced time to ACR, but not to an increased likelihood of ACR at 6 months, a study has shown.

Filgrastim tied to higher ACR burden in lung transplant recipients

15 Aug 2024

Cytisinicline for vaping cessation turns in promising result in phase II trial

13 Aug 2024

Treatment with cytisinicline for 12 weeks, in addition to behavioural support, is well tolerated and appears to help e-cigarette users to quit vaping, according to the results of the phase II ORCA-V1 trial.

Cytisinicline for vaping cessation turns in promising result in phase II trial

13 Aug 2024

Several factors contribute to chronic cough in children

11 Aug 2024

Factors such as asthma, nitrogen oxide (NO2), home remodelling history, environmental tobacco smoke (ETS), pet, mould, and age＜1 year appear to predispose children to chronic coughing, according to the results of a meta-analysis.

Several factors contribute to chronic cough in children

11 Aug 2024

Garsorasib shows therapeutic potential in KRASG12C-mutated NSCLC

11 Aug 2024

The investigational garsorasib, a potent KRASG12C inhibitor, appears to induce high response rate while having a manageable safety profile in patients with previously treated KRASG12C-mutated non–small cell lung cancer (NSCLC), according to the results of a phase II study.